Cargando…

Modelling the impact of extended vaccination strategies on the epidemiology of pertussis

The aim of this study was to investigate the optimal pertussis booster vaccination strategy for The Netherlands. A realistic age-structured deterministic model was designed. Assuming a steady-state situation and correcting for underreporting, the model was calibrated using notification data from the...

Descripción completa

Detalles Bibliográficos
Autores principales: ROZENBAUM, M. H., De VRIES, R., LE, H. H., POSTMA, M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404482/
https://www.ncbi.nlm.nih.gov/pubmed/22115361
http://dx.doi.org/10.1017/S0950268811002354
_version_ 1782239016339374080
author ROZENBAUM, M. H.
De VRIES, R.
LE, H. H.
POSTMA, M. J.
author_facet ROZENBAUM, M. H.
De VRIES, R.
LE, H. H.
POSTMA, M. J.
author_sort ROZENBAUM, M. H.
collection PubMed
description The aim of this study was to investigate the optimal pertussis booster vaccination strategy for The Netherlands. A realistic age-structured deterministic model was designed. Assuming a steady-state situation and correcting for underreporting, the model was calibrated using notification data from the period 1996–2000. Several sensitivity analyses were performed to explore the impact of different assumptions for parameters surrounded by uncertainty (e.g. duration of protection after natural infection, underreporting factors, and transmission probabilities). The optimal age of an additional booster dose is in the range of 10–15 years, and implementation of this booster dose will reduce both symptomatic and asymptomatic infections, although the incidence of symptomatic infections in older age groups will increase. The impact of the different assumptions used in the model was in general limited. We conclude that over a wide range of assumptions, an additional booster dose can reduce the incidence of pertussis in the population.
format Online
Article
Text
id pubmed-3404482
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-34044822012-07-27 Modelling the impact of extended vaccination strategies on the epidemiology of pertussis ROZENBAUM, M. H. De VRIES, R. LE, H. H. POSTMA, M. J. Epidemiol Infect Original Papers The aim of this study was to investigate the optimal pertussis booster vaccination strategy for The Netherlands. A realistic age-structured deterministic model was designed. Assuming a steady-state situation and correcting for underreporting, the model was calibrated using notification data from the period 1996–2000. Several sensitivity analyses were performed to explore the impact of different assumptions for parameters surrounded by uncertainty (e.g. duration of protection after natural infection, underreporting factors, and transmission probabilities). The optimal age of an additional booster dose is in the range of 10–15 years, and implementation of this booster dose will reduce both symptomatic and asymptomatic infections, although the incidence of symptomatic infections in older age groups will increase. The impact of the different assumptions used in the model was in general limited. We conclude that over a wide range of assumptions, an additional booster dose can reduce the incidence of pertussis in the population. Cambridge University Press 2012-08 2011-11-24 /pmc/articles/PMC3404482/ /pubmed/22115361 http://dx.doi.org/10.1017/S0950268811002354 Text en Copyright © Cambridge University Press 2011 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>. The written permission of Cambridge University Press must be obtained for commercial re-use. http://creativecommons.org/licenses/by-nc-sa/2.5/ The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>. (http://creativecommons.org/licenses/by-nc-sa/2.5/>) The written permission of Cambridge University Press must be obtained for commercial re-use.
spellingShingle Original Papers
ROZENBAUM, M. H.
De VRIES, R.
LE, H. H.
POSTMA, M. J.
Modelling the impact of extended vaccination strategies on the epidemiology of pertussis
title Modelling the impact of extended vaccination strategies on the epidemiology of pertussis
title_full Modelling the impact of extended vaccination strategies on the epidemiology of pertussis
title_fullStr Modelling the impact of extended vaccination strategies on the epidemiology of pertussis
title_full_unstemmed Modelling the impact of extended vaccination strategies on the epidemiology of pertussis
title_short Modelling the impact of extended vaccination strategies on the epidemiology of pertussis
title_sort modelling the impact of extended vaccination strategies on the epidemiology of pertussis
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404482/
https://www.ncbi.nlm.nih.gov/pubmed/22115361
http://dx.doi.org/10.1017/S0950268811002354
work_keys_str_mv AT rozenbaummh modellingtheimpactofextendedvaccinationstrategiesontheepidemiologyofpertussis
AT devriesr modellingtheimpactofextendedvaccinationstrategiesontheepidemiologyofpertussis
AT lehh modellingtheimpactofextendedvaccinationstrategiesontheepidemiologyofpertussis
AT postmamj modellingtheimpactofextendedvaccinationstrategiesontheepidemiologyofpertussis